| P2093 | author name string | Shirley Campbell | |
| | Audrey Claing | |
| | Louis Gaboury | |
| | Sarah Pasquin | |
| | Sabrina Schlienger | |
| P2860 | cites work | Critical role of c-Jun overexpression in liver metastasis of human breast cancer xenograft model | Q21260411 |
| | Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities | Q24555819 |
| | ARF6-JIP3/4 regulate endosomal tubules for MT1-MMP exocytosis in cancer invasion | Q27309213 |
| | ADP-ribosylation factor-dependent phospholipase D activation by the M3 muscarinic receptor | Q28178279 |
| | Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? | Q29547559 |
| | ARF proteins: roles in membrane traffic and beyond | Q29618078 |
| | v-Src SH3-enhanced interaction with focal adhesion kinase at beta 1 integrin-containing invadopodia promotes cell invasion | Q30167613 |
| | Beta-catenin phosphorylated at serine 45 is spatially uncoupled from beta-catenin phosphorylated in the GSK3 domain: implications for signaling | Q30436381 |
| | Active Arf6 recruits ARNO/cytohesin GEFs to the PM by binding their PH domains. | Q30444590 |
| | Endogenous ARF6 interacts with Rac1 upon angiotensin II stimulation to regulate membrane ruffling and cell migration | Q30445163 |
| | ARF1 regulates the Rho/MLC pathway to control EGF-dependent breast cancer cell invasion | Q30560783 |
| | Requirement for Arf6 in breast cancer invasive activities | Q33696335 |
| | Independent interactions of phosphorylated β-catenin with E-cadherin at cell-cell contacts and APC at cell protrusions | Q33770272 |
| | Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer | Q33915005 |
| | MMP-9 expression varies according to molecular subtypes of breast cancer | Q34116451 |
| | Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion | Q34231975 |
| | Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene | Q34253422 |
| | T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes | Q34253435 |
| | GEP100 links epidermal growth factor receptor signalling to Arf6 activation to induce breast cancer invasion. | Q34726188 |
| | lincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6. | Q35108871 |
| | Stromal cells in tumor microenvironment and breast cancer | Q35609967 |
| | Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling | Q36053060 |
| | Comparison of doxycycline delivery methods for Tet-inducible gene expression in a subcutaneous xenograft model | Q36114046 |
| | Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses | Q36299131 |
| | Overexpression of annexin 1 in pancreatic cancer and its clinical significance | Q36308123 |
| | Induction of cell scattering by expression of beta1 integrins in beta1-deficient epithelial cells requires activation of members of the rho family of GTPases and downregulation of cadherin and catenin function | Q36313391 |
| | PTEN-deficient cancers depend on PIK3CB. | Q36861839 |
| | ADP-ribosylation factor 1 controls the activation of the phosphatidylinositol 3-kinase pathway to regulate epidermal growth factor-dependent growth and migration of breast cancer cells | Q37142842 |
| | JNK phosphorylates beta-catenin and regulates adherens junctions | Q37415830 |
| | Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas | Q37641907 |
| | Overexpression of ADP-ribosylation factor 1 in human gastric carcinoma and its clinicopathological significance | Q37682026 |
| | Epidermal growth factor receptor in triple-negative and basal-like breast cancer: promising clinical target or only a marker? | Q37694203 |
| | Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics | Q38318356 |
| | ARF1 regulates adhesion of MDA-MB-231 invasive breast cancer cells through formation of focal adhesions | Q38926448 |
| | ASPP1 and ASPP2 bind active RAS, potentiate RAS signalling and enhance p53 activity in cancer cells | Q39197882 |
| | ARF1 controls proliferation of breast cancer cells by regulating the retinoblastoma protein | Q39561478 |
| | Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma | Q39852633 |
| | Single-vector inducible lentiviral RNAi system for oncology target validation | Q39889810 |
| | Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells | Q40723154 |
| | A role for focal adhesion kinase in hyluronan-dependent MMP-2 secretion in a human small-cell lung carcinoma cell line, QG90. | Q40756412 |
| | Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma | Q42466578 |
| | Phosphorylation of focal adhesion kinase at tyrosine 861 is crucial for Ras transformation of fibroblasts | Q42829238 |
| | Biological characteristics of interval cancers: a role for biomarkers in the breast cancer screening. | Q45847753 |
| | Determination of subcutaneous tumor size in athymic (nude) mice | Q46296687 |
| | Lack of in vitro-in vivo correlation of a novel investigational anticancer agent, SH 30. | Q53971414 |
| | Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update | Q57130157 |
| | The amino terminus of ADP-ribosylation factor (ARF) is a critical determinant of ARF activities and is a potent and specific inhibitor of protein transport | Q68184702 |
| | Regulated exocytosis in chromaffin cells. A potential role for a secretory granule-associated ARF6 protein | Q73009352 |
| | [WHO classification of breast tumors and tumors of the female genital organs: pathology and genetics] | Q73150850 |
| | Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models | Q73208103 |
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 15811-15827 | |
| P577 | publication date | 2016-02-18 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer | |
| P478 | volume | 7 | |